The Ontario Pharmacy Evidence Network Atlas of MedsCheck services

Institute of Medicine. Preventing medication errors: quality chasm series. Washington (DC): National Academies Press; 2007.

Hakkarainen KM Sundell KA Petzold M Hägg S . Prevalence and perceived preventability of self-reported adverse drug events: a population-based survey of 7099 adults. PLoS One. 2013;8(9):e73166.6

Maher RL Hanlon JT Hajjar ER . Clinical consequences of polypharmacy in the elderly. Expert Opin Drug Saf. 2014;13(1):57-65.

Sichieri K Rodrigues ARB Takahashi JA , et al. Mortality associated with the use of inappropriate drugs according Beers criteria: a systematic review. Adv Pharmacol Pharm. 2013;1(2):74-84.

Zed PJ Haughn C Black KJL , et al. Medication-related emergency department visits and hospital admissions in pediatric patients: a qualitative systematic review. J Pediatr. 2013;163(2):477-83.

Huiskes VJB Burger DM van den Ende CHM van den Bemt BJF . Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract. 2017;18(1):5.

Pammett R Jorgenson D . Eligibility requirements for community pharmacy medication review services in Canada. Can Pharm J (Ott). 2014;147(1):20-4.

Shakeri A Dolovich L MacCallum L Gamble JM Zhou L Cadarette SM . Impact of the 2016 policy change on the delivery of MedsCheck services in Ontario: an interrupted time-series analysis. Pharmacy. 2019;7(3):115.

Cadarette SM He N Chaudhry M Dolovich L . The Ontario Pharmacy Evidence Network interactive atlas of professional pharmacy services. Can Pharm J (Ott). 2021;154:153-9.

OPEN. Ontario Pharmacy Evidence Network Interactive Atlas Tool. Available: https://www.pharmacy.utoronto.ca/research/centres-initiatives/centre-practice-excellence/open-interactive-atlas-professional-pharmacist-services (accessed Feb. 15, 2021)

Queen’s Printer for Ontario. Long-term care overview. Published November 2019. Available: https://www.ontario.ca/page/about-long-term-care (accessed Aug. 15, 2020).

Ministry of Health and Long-term Care. Professional pharmacy services guidebook 3.0. Toronto (Ontario): Queen’s Printer for Ontario; 2016. Available: http://www.health.gov.on.ca/en/pro/programs/drugs/medscheck/docs/guidebook.pdf (accessed Oct. 1, 2018).

Rose O Cheong V-L Dhaliwall S , et al. Standards in medication review: an international perspective. Can Pharm J (Ott). 2020;153(4):215-23.

Raiche T Pammett R Dattani S , et al. Community pharmacists’ evolving role in Canadian primary health care: a vision of harmonization in a patchwork system. Pharm Pract. 2020;18(4):2171.

Shane A Argáez C . Pharmacist-led medication reviews: a review of clinical utility and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health; 09062019.

Kolhatkar A Cheng L Chan FKI Harrison M Law MR . The impact of medication reviews by community pharmacists. J Am Pharm Assoc. 2016;56(5):513-20.e1.

Currie K Evans C Mansell K Perepelkin J Jorgenson D . Community pharmacists’ experiences with the Saskatchewan Medication Assessment Program. Can Pharm J (Ott). 2019;152(3):193-203.

Jokanovic N Tan ECK Sudhakaran S , et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Soc Adm Pharm. 2017;13(4):661-85.

Messerli M Blozik E Vriends N Hersberger KE . Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy—a prospective randomised controlled trial. BMC Health Serv Res. 2016;16(1):145.

Lapointe-Shaw L Bell CM Austin PC , et al. Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study. BMJ Qual Saf. 2020;29(1):41-51.

Ministry of Health. Notice: policy for pharmacy payments under the long-term care home capitation funding model, 2020. Toronto (Canada): Queen’s Printer for Ontario; 2020:13. Available: www.health.gov.on.ca/en/pro/programs/drugs/opdp_eo/notices/exec_office_20191216_2.pdf (accessed Sep. 17, 2020).

Queen’s Printer for Ontario. Statement from Premier Ford, Minister Elliott, and Minister Lecce on the 2019 novel coronavirus (COVID-19). Office of the Premier. Published March 12, 2020. Available: https://news.ontario.ca/en/statement/56270/title (accessed Sep. 17, 2020).

Queen’s Printer for Ontario. Ontario enacts declaration of emergency to protect the public. Office of the Premier. Published March 17, 2020. Available: https://news.ontario.ca/en/release/56356/ontario-enacts-declaration-of-emergency-to-protect-the-public (accessed Sep. 17, 2020).

Queen’s Printer for Ontario. Ontario extends emergency orders to help stop the spread of COVID-19. Office of the Premier. Published April 23, 2020. Available: https://news.ontario.ca/en/release/56746/ontario-extends-emergency-orders-to-help-stop-the-spread-of-covid-19 (accessed Sep. 17, 2020).

Ontario Pharmacists Association. COVID-19 pandemic: a pharmacist’s guide to pandemic preparedness. 2020:23. Available: https://www.opatoday.com/Media/Default/Default/2020-03-17%20OPA%20GUIDE%20FOR%20PANDEMIC%20PREPAREDNESS_FINAL.pdf (accessed Sep. 17, 2020).

Ministry of Health. Notice: Ontario Drug Benefit (ODB) program changes and guidance for dispensers during the COVID-19 public health emergency. Published March 20, 2020. Available: https://www.ona.org/wp-content/uploads/covid19_odbprogramchangesandguidancefordispensers_20200320.pdf (accessed Sep. 17, 2020).

Ministry of Health. Executive officer notice: removal of the 30-days’ supply dispensing limit recommendation. Published June 12, 2020. Available: http://www.health.gov.on.ca/en/pro/programs/drugs/opdp_eo/notices/exec_office_20200612.pdf

Chaudhry M He N Waite NM Houle SKD Kwong JC Cadarette SM . The Ontario Pharmacy Evidence Network Atlas of community pharmacy influenza immunization services. Can Pharm J. 2021;154(5):305-11.

Poudel A Lau ETL Deldot M Campbell C Waite NM Nissen LM . Pharmacist role in vaccination: evidence and challenges. Vaccine. 2019;37(40):5939-45.